El-Shahat A Toson
Overview
Explore the profile of El-Shahat A Toson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abo-Ser M, Toson E, El-Bindary A, Schlatter G, Shoueir K
Int J Biol Macromol
. 2024 Apr;
267(Pt 1):131390.
PMID: 38582473
In recent decades, bio-polymeric nanogels have become a forefront in medical research as innovative in-vivo drug carriers. This study introduces a pH-sensitive chitosan nanoparticles/P(N-Isopropylacrylamide-co-Acrylic acid) nanogel (CSNPs/P(NIPAm-co-AAc)), making significant advancements....
2.
Toson E, Saad E, Omar H
Environ Sci Pollut Res Int
. 2021 Aug;
29(5):6399-6413.
PMID: 34449021
Several studies have reported the toxicological implications of exposure to petroleum hydrocarbon fumes in animal models. There is little documentation on the effect of such exposure on oxidative stress levels...
3.
Toson E, Shiha G, El-Sharkawy A, El-Mezayen H
Eur J Gastroenterol Hepatol
. 2019 Nov;
32(8):990-997.
PMID: 31743229
Background/aim: Liver fibrosis assessment and evaluation of disease severity in hepatitis C virus (HCV) patients provides useful information for therapeutic decisions. Chronic HCV infection is associated with increased levels of...
4.
Toson E, Shiha G, Abdelgaleel A
Ann Hepatol
. 2017 Oct;
16(6):862-873.
PMID: 29055924
Results: Samples were collected from 220 patients (F0-F4): an estimated group (n = 120) and a validated group (n = 100). HA and VEGF levels, HCV RNA, liver function tests,...
5.
Toson E, Shiha G, El-Mezayen H, Samir W, El-Khininy M
Eur J Gastroenterol Hepatol
. 2016 Dec;
29(2):199-207.
PMID: 27930387
Background/aim: The assessment of liver fibrosis provides useful information not only for diagnosis but also for therapeutic decisions. This study aimed to develop and evaluate a predictive score named the...
6.
El-Mezayen H, Toson E, Darwish H, Metwally F
Med Oncol
. 2013 Jan;
30(1):404.
PMID: 23275142
Tumor metastasis involves the dissemination of malignant cells into the basement membrane, and the vascular system contributes to the circulating pool of these markers. In this context, our aim has...
7.
El-Mezayen H, Toson E, Shiha G
Eur J Gastroenterol Hepatol
. 2012 Sep;
25(1):69-76.
PMID: 23011038
Background/aims: Liver biopsy is considered a gold standard for fibrosis staging, but it has a high risk of morbidity. Therefore, there is an interest in developing noninvasive markers for the...
8.
El-Mezayen H, Toson E, Darwish H, El-Badry E
Tumour Biol
. 2012 Jan;
33(4):995-1004.
PMID: 22278154
Colorectal cancer (CRC) is one of the most common causes of cancer-related deaths worldwide. Because there is currently no useful serological marker for metastatic colorectal cancer, the search for simple...
9.
Attallah A, Toson E, El-Waseef A, Abo-Seif M, Omran M, Shiha G
Clin Chim Acta
. 2006 Mar;
369(1):66-72.
PMID: 16545356
Background/aims: The invasive liver biopsy is still considered the gold standard for assessing patients with chronic hepatitis C (CHC). Our aim was to determine the operating characteristics of a non-invasive...